AstraZeneca: enters collaboration with France's Genomic.

(CercleFinance.com) - AstraZeneca has agreed to enter into a technological collaboration with France's Genomic Vision, a company that specialises in diagnostic tests for the early detection of cancers and genetic diseases.


The collaboration agreement will be based on the use of the molecular combing by AstraZeneca so as to evaluate the impact of kinase inhibitors on DNA replication progression in cancer cells.

The idea is to target DNA damage response for novel anti-cancer treatments strategy, the two companies said in a statement.

Copyright (c) 2017 CercleFinance.com. All rights reserved.